Skip to content
Screener

AptarGroup ATR Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$6.9M+97.1%
Amcor logo
AmcorAMCR
$6M+500%
AMP
Amphastar PharmaceuticalsAMPH
$1.98M
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$12.09M+3,405%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$42K-93.9%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$1K

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$8.69B-4.7%
Enterprise value$9.9B-2.2%
P/E22.5×-0.8×
P/S2.3×-0.3×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The source filing: AptarGroup’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:22 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000896622-26-000092
In thousands, brackets denote cash outflows / Three Months Ended March 31,20262025
Repayments of long-term obligations(127,927)(4,552)
Payment of contingent consideration obligation(2,197)
Dividends paid(30,920)(29,923)
Proceeds from stock option exercises18,5163,375
Purchase of treasury stock(99,973)(80,000)
Redeemable noncontrolling interest89
Net Cash Used by Financing Activities(230,340)(134,777)
Effect of Exchange Rate Changes on Cash(3,150)10,662

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is AptarGroup's stock issuance proceeds?
AptarGroup (ATR) reported stock issuance proceeds of $18.52M in Q1 2026.
How has AptarGroup's stock issuance proceeds changed year-over-year?
AptarGroup's stock issuance proceeds increased by 448.6% year-over-year, from $3.38M to $18.52M.
What is the long-term trend for AptarGroup's stock issuance proceeds?
Over 4 years (2021 to 2025), AptarGroup's stock issuance proceeds has grown at a -25.1% compound annual growth rate (CAGR), from $59.91M to $18.89M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Ask your AI about AptarGroup's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude